US19207A1088 - Common Stock
COEPTIS THERAPEUTICS HOLDING
NASDAQ:COEP (12/27/2024, 8:12:17 PM)
After market: 0.1601 -0.02 (-12.13%)0.1822
-0.03 (-13.65%)
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company. The company is headquartered in Wexford, Pennsylvania and currently employs 5 full-time employees. The company went IPO on 2020-12-17. The firm owns, acquires, and develops cell therapy technologies for cancer and other diseases. Its product portfolio and rights are highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company is developing a universal, multi-antigen chimeric antigen receptor (CAR) T technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms, which the Company is developing with VyGen-Bio and medical researchers at the Karolinska Institute. Its CAR therapy is a treatment for cancer in which a patient's T cells are genetically engineered to recognize cancer cells to target and destroy them.
COEPTIS THERAPEUTICS HOLDING
105 Bradford Road, Suite 420
Wexford PENNSYLVANIA
P: 17249346467
Employees: 5
Website: https://coeptistx.com/
Let's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shares are trading lower on Friday. The firm announced plans to implement a 1-for-20 reverse stock split, which will take effect on December 31. The decision follows authorization from the company's board of directors and majority stockholders. The reverse stock split aims to help the company meet the Nasdaq Capital Market's minimum bid price requirement of $1.00 per share, which is necessary to maintain its listing on the exchange. Also Read: 3
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
/PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy...
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Here you can normally see the latest stock twits on COEP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: